Best Practices for Safety, Workflow When Using Hazardous Agents

Directions in Pharmacy

Managing Toxicities Associated With Immune Checkpoint Inhibitors

Directions in Pharmacy

Pharmacy-Integrated Telehealth Solutions Support Patients with Orphan and Ultraorphan Disorders During and After COVID-19 Pandemic

Directions in Pharmacy

Breast Cancer Testing, Counseling, and Toxicity Management Are Essential for Optimal Oncology Care

Directions in Pharmacy

CAR-NK Cell Immunotherapy Demonstrates Potential for Treating Patients With Relapsed or Refractory Lymphomas

Directions in Pharmacy

Recent Developments in Therapeutics for GIST, Non–Small Cell Lung Cancer

Directions in Pharmacy

Rising to Meet the Challenges of COVID-19 in Cancer Care

Directions in Pharmacy

The New Norm in Oncology Pharmacy

Directions in Pharmacy

Oncology Drug Pipeline Is Poised to Offer Potential New Therapies in the Next Year

Directions in Pharmacy

Brown Bag Consult: Offering Preventative Cancer Care in the Community Pharmacy

Directions in Pharmacy

Cancer Care During the COVID-19 Pandemic

Directions in Pharmacy

Essential Updates in Acute Graft-Versus-Host Disease

Directions in Pharmacy

Spotlight on BTK Inhibitors in the Management of B-Cell Malignancies

Directions in Pharmacy

Practice-Changing Clinical Pearls in Relapsed or Refractory Multiple Myeloma

Directions in Pharmacy

Pharmacist Contributions to Patient Care in Cervical and Endometrial Cancers: From Prevention to Metastatic Disease

Directions in Pharmacy

CE: Managing Chronic Immune Thrombocytopenia: Opportunities for Oncology Pharmacists to Optimize Patient Care

Directions in Pharmacy

Bispecific Antibodies: The Next Generation of Immunotherapy

Directions in Pharmacy

Program Offering Enhanced Reimbursement for High-Quality Drugs Impacts Prescribing Patterns

Directions in Pharmacy

Rare Pharmacy Emerges From Specialty, Part 3